154 related articles for article (PubMed ID: 6139020)
1. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
2. Labetalol infusion in hypertensive emergencies.
Lebel M; Langlois S; Belleau LJ; Grose JH
Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
[TBL] [Abstract][Full Text] [Related]
3. Step II treatment with labetalol for essential hypertension.
Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
[TBL] [Abstract][Full Text] [Related]
5. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial.
Wallin JD; Wilson D; Winer N; Maronde RF; Michelson EL; Langford H; Maloy J; Poland M
Am J Med; 1983 Oct; 75(4A):87-94. PubMed ID: 6356903
[TBL] [Abstract][Full Text] [Related]
7. Intravenous labetalol in the emergency treatment of hypertension.
Vidt DG
J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
[TBL] [Abstract][Full Text] [Related]
8. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
9. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
Frishman WH; Michelson EL; Johnson BF; Poland MP
Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency.
Huey J; Thomas JP; Hendricks DR; Wehmeyer AE; Johns LJ; MacCosbe PE
Am J Hypertens; 1988 Jul; 1(3 Pt 3):284S-289S. PubMed ID: 3415804
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
12. Oral labetalol in hypertensive urgencies.
Zell-Kanter M; Leikin JB
Am J Emerg Med; 1991 Mar; 9(2):136-8. PubMed ID: 1994940
[TBL] [Abstract][Full Text] [Related]
13. Labetalol in essential hypertension.
Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
[TBL] [Abstract][Full Text] [Related]
14. Intravenous labetalol in hypertensive patients given by fast and slow injection.
Pearson RM; Havard CW
Br J Clin Pharmacol; 1978 May; 5(5):401-5. PubMed ID: 350248
[TBL] [Abstract][Full Text] [Related]
15. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
[TBL] [Abstract][Full Text] [Related]
16. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
Milne BJ; Logan AG
Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
[TBL] [Abstract][Full Text] [Related]
18. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
[TBL] [Abstract][Full Text] [Related]
19. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
Weber MA; Drayer JI; Kaufman CA
J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]